Seppo Helisalmi

14.5k total citations
132 papers, 4.5k citations indexed

About

Seppo Helisalmi is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Seppo Helisalmi has authored 132 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Physiology, 34 papers in Molecular Biology and 29 papers in Neurology. Recurrent topics in Seppo Helisalmi's work include Alzheimer's disease research and treatments (71 papers), Dementia and Cognitive Impairment Research (27 papers) and Pregnancy and preeclampsia studies (14 papers). Seppo Helisalmi is often cited by papers focused on Alzheimer's disease research and treatments (71 papers), Dementia and Cognitive Impairment Research (27 papers) and Pregnancy and preeclampsia studies (14 papers). Seppo Helisalmi collaborates with scholars based in Finland, Sweden and United States. Seppo Helisalmi's co-authors include Hilkka Soininen, Maarit Lehtovirta, Mikko Hiltunen, Arto Mannermaa, Irina Alafuzoff, Markku Ryynänen, Päivi Hartikainen, Paavo Riekkinen, Sanna‐Kaisa Herukka and Anne M. Koivisto and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Neurology.

In The Last Decade

Seppo Helisalmi

132 papers receiving 4.4k citations

Peers

Seppo Helisalmi

PHYSI

PMH

NEURO

CMN

Sun Hyung Joo South Korea

Roberta Ghidoni Italy

Richard Crook United States

Luisa Benussi Italy

A D Roses United States

Tuomo Polvikoski United Kingdom

Zsuzsanna Nagy United Kingdom

Alberto Pupi Italy

B.L. Rosi United States

Aarti R. Shah United States

Sun Hyung Joo South Korea

Seppo Helisalmi

3.1k ×1.3

PHYSI

1.1k ×0.9

PMH

1.7k ×1.5

551 ×0.7

NEURO

707 ×1.0

CMN

Citations per year, relative to Seppo Helisalmi Seppo Helisalmi (= 1×) peers Sun Hyung Joo

Countries citing papers authored by Seppo Helisalmi

Since Specialization

Citations

This map shows the geographic impact of Seppo Helisalmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppo Helisalmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppo Helisalmi more than expected).

Fields of papers citing papers by Seppo Helisalmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seppo Helisalmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppo Helisalmi. The network helps show where Seppo Helisalmi may publish in the future.

Co-authorship network of co-authors of Seppo Helisalmi

This figure shows the co-authorship network connecting the top 25 collaborators of Seppo Helisalmi. A scholar is included among the top collaborators of Seppo Helisalmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seppo Helisalmi. Seppo Helisalmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valtola, Kati, Marja Hedman, Ilkka Kantola, et al.. (2023). Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation. Open Heart. 10(1). e002251–e002251. 6 indexed citations

Silva, Lilian Fernandes, et al.. (2022). Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study. Metabolites. 12(5). 437–437. 2 indexed citations

Jääskeläinen, Olli, Anette Hall, Mika Tiainen, et al.. (2020). Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease. Journal of Alzheimer s Disease. 74(1). 277–286. 19 indexed citations

Martikainen, Ilkka K., Nina Kemppainen, Jan Johansson, et al.. (2019). Brain beta-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 2 indexed citations

Martikainen, Ilkka K., Nina Kemppainen, Jarkko Johansson, et al.. (2018). Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline. American Journal of Neuroradiology. 40(1). 80–85. 13 indexed citations

Solomon, Alina, Heidi Turunen, Tiia Ngandu, et al.. (2018). Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention A Subgroup Analysis of a Randomized Clinical Trial. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 8 indexed citations

Katisko, Kasper, Eino Solje, Anne M. Koivisto, et al.. (2018). Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers. Journal of Neuroimmunology. 321. 29–35. 18 indexed citations

Katisko, Kasper, Annakaisa Haapasalo, Anne M. Koivisto, et al.. (2018). Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration. Journal of Alzheimer s Disease. 62(2). 789–794. 8 indexed citations

Stephen, Ruth, Yawu Liu, Tiia Ngandu, et al.. (2017). Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. Journal of Alzheimer s Disease. 59(2). 695–705. 49 indexed citations

10.

Solje, Eino, Jouko Miettunen, Seppo Helisalmi, et al.. (2016). The C9ORF72 expansion sizes in patients with psychosis. Psychiatric Genetics. 26(2). 92–94. 11 indexed citations

11.

Alafuzoff, Irina, et al.. (2008). β‐Amyloid deposition in brains of subjects with diabetes. Neuropathology and Applied Neurobiology. 35(1). 60–68. 83 indexed citations

12.

Hiltunen, Mikko, et al.. (2006). Adiponectin Gene Haplotype Is Associated with Preeclampsia. Genetic Testing. 10(1). 35–39. 16 indexed citations

13.

Pirskanen, Mia, Mikko Hiltunen, Seppo Helisalmi, et al.. (2005). Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. European Journal of Human Genetics. 13(9). 1000–1006. 67 indexed citations

14.

Hiltunen, Mikko, et al.. (2003). Plasminogen Activator Inhibitor-1 Polymorphism in Women with Pre-eclampsia. Genetic Testing. 7(3). 265–268. 11 indexed citations

15.

Hiltunen, Mikko, et al.. (2003). Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation. European Journal of Human Genetics. 12(3). 187–191. 17 indexed citations

16.

Hiltunen, Mikko, Seppo Helisalmi, Arto Mannermaa, et al.. (2000). Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?. European Journal of Human Genetics. 8(4). 259–266. 38 indexed citations

17.

Overmyer, Margit, Michał Kraszpulski, Seppo Helisalmi, Hilkka Soininen, & Irina Alafuzoff. (2000). DNA fragmentation, gliosis and histological hallmarks of Alzheimer's disease. Acta Neuropathologica. 100(6). 681–687. 13 indexed citations

18.

Helisalmi, Seppo, Mikko Hiltunen, Piia Valonen, et al.. (1999). Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. Journal of Neurology. 246(9). 821–824. 28 indexed citations

19.

Hiltunen, Mikko, Arto Mannermaa, Seppo Helisalmi, et al.. (1998). Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neuroscience Letters. 250(1). 69–71. 37 indexed citations

20.

Lehtovirta, Maarit, Hilkka Soininen, Mikko P. Laakso, et al.. (1996). SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.. Journal of Neurology Neurosurgery & Psychiatry. 60(6). 644–649. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact